Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study

References

• Guo B, Page A, Wang H, Taylor R, McIntyre P. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Vaccine. 2013;31(4):603–8. doi:10.1016/j.vaccine.2012.11.051.
   PubMed Web of Science ®Google Scholar
• China, N.H.C.o.t.P.s.R.o. Immunization schedules and instructions for vaccines of the national immunization program (2021 version). Chin J Viral Dis. 2021;11(4):241.
   Google Scholar
• Vaccines, I.S.G.a.E.C.C.A.f. Expert consensus on the use of combination vaccine and simultaneous immunization in children aged 0–12 months. Chin J Prev Med. 2022;56(8):1035–41.
   Google Scholar
• WHO. WHO recommendations for routine immunization summary tables. WHO; 2023. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization---summary-tables#.
   Google Scholar
• Vaccine Administration Law of the People’s Republic of China. 2019.
   Google Scholar
• Liu B, Cao B, Wang C, Sun T, Miao Y, Zhang S, Zhao T, Cui F. Cost-minimization analysis of DTaP-IPV-Hib combination vaccine in China: a nationwide cross-sectional study. Basel: Vaccines; 2022. (1096–9071 (Electronic)).
   Google Scholar
• Loiacono MM, Pool V, van Aalst R. DTaP combination vaccine use and adherence: a retrospective cohort study. Epub: Vaccine; 2021. (1873–2518 (Electronic)).
   Google Scholar
• Ming-bo, M.D.-c.S. Research progress of combination vaccines. Chin J Vaccines Immun. 2016;2016(6):697–701.
   Google Scholar
• Gilkey MB, McRee, AL, Magnus, BE, Reiter, PL, Dempsey, AF, Brewer, NT. Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines. Epub: PLoS One; 2016. (1932–6203 (Electronic)).
   Google Scholar
• Karafillakis E, Larson HJ. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine; 2017. (1873–2518 (Electronic)).
   Google Scholar
• Karafillakis EL, Larson HJ. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35:4840–50. doi:10.1016/j.vaccine.2017.07.061.
   PubMed Web of Science ®Google Scholar
• Smith LE, Amlôt R, Weinman J, Yiend J, Rubin GJ. A systematic review of factors affecting vaccine uptake in young children. Vaccine. 2017;35(45):6059–69. doi:10.1016/j.vaccine.2017.09.046.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Vidor, E, Tsuzuki, D, Nishina, S, Sasaki, T, Ishii, Y, Mizukami, H, Tsuge, H. Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan. Epub: J Infect Chemother; 2020. (1437–7780 (Electronic)).
   Google Scholar
• Lin TY, Wang YH, Chang LY, Chiu CH, Huang YC, Tang H, Bock HL. Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age. Chang Gung Medical Journal; 2003. (2072–0939 (Print)).
   Google Scholar
• Kang JA-O, Lee HJ, Kim KH, Oh SH, Cha SH, Lee J, Kim NH, Eun BW, Kim CH, Hong YJ, Kim HH. The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants. Journal of Korean Medical Science; 2016. (1598–6357 (Electronic)).
   Google Scholar
• Hebei Province census yearbook. Hebei provincial Bureau of Statistics; 2020. http://tjj.hebei.gov.cn/extra/col20/rkpc2020/zk/indexce.htm.
   Google Scholar
• National Medical Products Administration. National surveillance program for suspected abnormal response to vaccination. 2022.
   Google Scholar
• Amarasinghe A, Cho H, Katalbas ER, Takashima Y. COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021–2022. West Pac Surveill Response J. 2023;14(2) (2094-7313 (Electronic)): p. 1–11. doi:10.5365/wpsar.2023.14.2.1046.
   Google Scholar
• National Health Commission of the People’s Republic of, C. Childhood immunization schedule for National immunization program vaccines — China (version 2021). China CDC Weekly. 2021;3(52):1101–8. doi:10.46234/ccdcw2021.270.
   PubMedGoogle Scholar
• Wu Wendi LD. Active surveillance of vaccine safety after marketing and its epidemiological research methods. Chin J Vaccines Immun. 2016;22(2):221–9,237.
   Google Scholar
• National Bureau of Statistics of China. Bulletin of the seventh national census. China; 2021.
   Google Scholar
• P KABLH. General best practice guidelines for immunization best practices guidance of the advisory committee on immunization practices (ACIP).
   Google Scholar
• Mangarule S PS, Kawade A. Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: a multi-center, randomized, controlled study. Vaccine X. 2022 Sep. 13(12):100216.
   Google Scholar
• Hansen J, Timbol J, Lewis N, Pool V, Decker MD, Greenberg DP, Klein NP. Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine; 2016. (1873-2518 (Electronic)).
   Google Scholar
• Sun Y, Christensen J, Hviid A, Li J, Vedsted P, Olsen J, Vestergaard M. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae Type B. JAMA. 2012;307(8):823–31. doi:10.1001/jama.2012.165.
   PubMed Web of Science ®Google Scholar
• Traversa G, Spila-Alegiani S, Bianchi C, Ciofi Degli Atti M, Frova L, Massari M, Raschetti R, Salmaso S, Scalia Tomba G, Hera Study Group. Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study. PLOS ONE. 2011;6(1):e16363. doi:10.1371/journal.pone.0016363.
   PubMed Web of Science ®Google Scholar
• Bauwens J, Saenz LH, Reusser A, Künzli N, Bonhoeffer J. Safety of Co-administration versus separate administration of the same vaccines in children: a systematic literature review. Vaccines. 2019;8(1):12. LID. [doi] LID - 12. (2076-393X (Print)). doi:10.3390/vaccines8010012.
   Web of Science ®Google Scholar
• Committee, C.V.I.A.i.s.g.a.e. Expert consensus on combined vaccine use and simultaneous vaccination in children aged 0-12 months. Chin J Epi. 2022;43(8):1171–7.
   Google Scholar
• Li YP, Li FX, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q. Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China. (0254–6450 (Print)).
   Google Scholar
• Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH. Antibody persistence at 18-20 months of age and safety and immunogenicity of abooster dose of acombined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People’s Republic of China. Vaccine. 2011 Nov 21;29(50):9337–44. doi: 10.1016/j.vaccine.2011.09.131.
   PubMed Web of Science ®Google Scholar
• Zheng Jingshan LD. Technical guide for the application of adsorbed acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b (conjugate) combined vaccine (DTaP-IPV/Hib pentagram vaccine). J South China Preventative Med. 2011;1(2). 67-71+74.
   Google Scholar
• National Health Commission, N.D.C.a.P.A. Code of practice for vaccination (2023 edition). Chin J Viral Dis. 2023;1(2):101–18.
   Google Scholar
• Ji Saisai LK, Wenti W, Disha X, Jiakai Y. Seasonal characteristics of suspected abnormal responses to vaccination in China in 2015-2016. Chin J Vaccines Immun. 2018;1(2):193–201.
   Google Scholar
• Zhang Lina LK, Yan L, Chunxiang F, Yuan L. Surveillance of suspected abnormal reactions to vaccination in China in 2020. Chin J Vaccines Immun. 2022;1(2):208–18.
   Google Scholar
• Li Keli ZL, Jiakai Y, Saisai J, Wenzhou Y. Surveillance of suspected abnormal reactions to vaccination in China in 2017. Chin J Vaccines Immun. 2020;1(1):9–18.
   Google Scholar
• Zhang Lina LK, Du W, Li Y, Chunxiang F. Surveillance of suspected abnormal reactions to vaccination in China in 2018. Chin J Vaccines Immun. 2020;1(4):363–71.
   Google Scholar
• Zhang Lina LK, Du W, Li Y, Chunxiang F. Surveillance of suspected abnormal reactions to vaccination in China in 2019. Chin J Vaccines Immun. 2021;1(4):438–45.
   Google Scholar
• Zhang Lina LK, Yan L, Fan Chunxiang LY, Minrui R, Wenzhou Y, Lei C, Lingsheng C, Zundong Y. Surveillance of adverse events following immunization in China，2020. Chin J Vaccines Immun. 2022;28:208–18.
   Google Scholar